Net profit of Supriya Lifescience rose 212.92% to Rs 29.79 crore in the quarter ended December 2023 as against Rs 9.52 crore during the previous quarter ended December 2022. Sales rose 33.22% to Rs 140.07 crore in the quarter ended December 2023 as against Rs 105.14 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales140.07105.14 33 OPM %29.6213.35 - PBDT44.0715.59 183 PBT40.1112.64 217 NP29.799.52 213 Powered by Capital Market - Live News

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 7 February 2024. The meeting would commence at 11.00 am.Powered by Capital Market - Live News

Net profit of Supriya Lifescience rose 41.64% to Rs 23.88 crore in the quarter ended September 2023 as against Rs 16.86 crore during the previous quarter ended September 2022. Sales rose 24.90% to Rs 140.10 crore in the quarter ended September 2023 as against Rs 112.17 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales140.10112.17 25 OPM %22.6625.46 - PBDT33.7630.39 11 PBT29.7827.42 9 NP23.8816.86 42 Powered by Capital Market - Live News

Supriya Lifesciences announced that the 15th Annual General Meeting (AGM) of the company will be held on 29 September 2023.Powered by Capital Market - Live News

Net profit of Supriya Lifescience rose 12.91% to Rs 28.51 crore in the quarter ended June 2023 as against Rs 25.25 crore during the previous quarter ended June 2022. Sales rose 30.25% to Rs 132.02 crore in the quarter ended June 2023 as against Rs 101.36 crore during the previous quarter ended June 2022. ParticularsQuarter Ended�Jun. 2023Jun. 2022% Var. Sales132.02101.36 30 OPM %33.7030.83 - PBDT46.5933.03 41 PBT42.6330.14 41 NP28.5125.25 13 Powered by Capital Market - Live News